Clinical Study

Utilization Of Adjuvant Chemotherapy In Patients With Pathologic Complete Response In Rectal Cancer

Posted Date: May 29, 2019

  • Investigator: Ian Paquette
  • Specialties:
  • Type of Study: Observational/Survey

NCCN guidelines recommend adjuvant chemotherapy in rectal cancer patients with pathologic complete response. This study will use the National Cancer Database (NCDB) to examined predictors to adherence to this guideline, and impact on survival.

Criteria:

Database Study

Keywords:

Rectal Cancer

For More Information:

Ian Paquette
NULL
ian.paquette@uc.edu


  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.